Biond Biologics Ltd. Revenue and Competitors
Estimated Revenue & Valuation
- Biond Biologics Ltd.'s estimated annual revenue is currently $9M per year.
- Biond Biologics Ltd.'s estimated revenue per employee is $201,000
Employee Data
- Biond Biologics Ltd. has 45 Employees.
- Biond Biologics Ltd. grew their employee count by 7% last year.
Biond Biologics Ltd.'s People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP R&D | Reveal Email/Phone |
2 | Chief Operating Officer (COO) | Reveal Email/Phone |
3 | Director Clinical Development | Reveal Email/Phone |
4 | General and Clinical lab manager | Reveal Email/Phone |
5 | Project Manager | Reveal Email/Phone |
6 | Researcher | Reveal Email/Phone |
7 | Researcher | Reveal Email/Phone |
8 | Researcher | Reveal Email/Phone |
9 | Project Leader | Reveal Email/Phone |
Biond Biologics Ltd. Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $46.2M | 230 | 5% | N/A | N/A |
#2 | $43.8M | 218 | 21% | N/A | N/A |
#3 | $57.1M | 284 | 26% | N/A | N/A |
#4 | $24.5M | 122 | 3% | N/A | N/A |
#5 | $52.9M | 263 | 13% | N/A | N/A |
#6 | $24.7M | 123 | 13% | N/A | N/A |
#7 | $1.8M | 18 | 0% | $114.3M | N/A |
#8 | $7.2M | 36 | -20% | N/A | N/A |
#9 | $13.7M | 68 | -7% | N/A | N/A |
#10 | $7.6M | 39 | -13% | $123.9M | N/A |
What Is Biond Biologics Ltd.?
Biond Biologics is a discovery and development company in the prosperous and evolving field of cancer immunotherapy and autoimmune disorders. Biond aims to translate high quality science into breakthrough therapies that will address unmet medical needs while focusing on innovative drugs. Biond is an Israeli company located at Galilee region, combining excellent science and out of the box innovation.
keywords:N/A
N/A
Total Funding
45
Number of Employees
$9M
Revenue (est)
7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Biond Biologics Ltd. News
2022-03-22 - Biond Biologics Announces Oral Presentation for BND-67, an ...
MISGAV, Israel, March 21, 2022 /PRNewswire/ -- Biond Biologics Ltd., a private, clinical-stage biopharmaceutical company developing novel...